Alkermes

Alkermes, Inc. is an integrated biotechnology company focused on developing, manufacturing, and commercializing medicines for chronic diseases. The company specializes in therapeutic areas such as central nervous system disorders, addiction, diabetes, and autoimmune disorders. Alkermes' key products include VIVITROL, an extended-release formulation of naltrexone used for treating alcohol dependence, and RISPERDAL CONSTA, an injectable medication for schizophrenia and bipolar I disorder. The company operates a research facility in Massachusetts and a commercial manufacturing facility in Ohio. Alkermes employs its proprietary technologies to create pharmaceutical products that address unmet medical needs, and it collaborates with third-party partners to enhance its product development efforts. With a significant presence in the United States, Alkermes also extends its operations to Ireland and other international markets.

Richard Pops

CEO

4 past transactions

Rodin Therapeutics

Acquisition in 2019
Rodin Therapeutics, a biotechnology company applying insights of epigenetics to novel therapeutics for neurological disorders, announced its founding by Atlas Venture and Proteros biostructures. Rodin is founded based on its insight into key epigenetic modulators of CNS function, privileged access to Proteros' best-in-class structural biology capabilities, and a team with deep CNS drug development and company formation experience. Rodin secured financing from Atlas Venture and Johnson & Johnson Development Corporation (JJDC).

Civitas Therapeutics

Series B in 2013
Civitas Therapeutics is a biopharmaceutical company that focuses on developing pulmonary delivery therapies. The Company develops therapeutics for the treatment of central nervous system and respiratory disorders. It serves patients throughout the United States.

Advanced Inhalation Research

Acquisition in 1999
Advanced Inhalation Research is a Biotechnology company.

Enzytech

Acquisition in 1993
Enzytech is a health care company that develops an injectable drug system for multiple sclerosis patients. The company is baed in Cambridge, Massachusetts.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.